A computational study of nicotine conformations in the gas phase and in water

Journal of Organic Chemistry

Volumn 65, Issue 3, 2000, Pages 742-747

  Elmore, Donald E ^a   Dougherty, Dennis A ^a  

^a California Institute of Technology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; PYRIDINE; PYRROLIDINE DERIVATIVE; WATER;

ARTICLE; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONFORMATION; GAS; PROTON TRANSPORT; SOLVATION; STEREOCHEMISTRY;

GASES; MOLECULAR CONFORMATION; NICOTINE; SOLUBILITY; THERMODYNAMICS; WATER;

EID: 0033975523     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo991383q     Document Type: Article

References (40)

1. For introductions to nicotine pharmacology and the interest in nicotinic agonists and antagonists, see: Bannon, A. W., et al. Science 1998, 279, 77-81. Holladay, M. W.; Dart, M. J.; Lynch, J. K. J. Med. Chem. 1997, 40, 4169-4194. Elgen, R. M.; Hunter, J. C.; Dray, A. Trends Pharm. Sci. 1999, 20, 337-342.
2. For introductions to nicotine pharmacology and the interest in nicotinic agonists and antagonists, see: Bannon, A. W., et al. Science 1998, 279, 77-81. Holladay, M. W.; Dart, M. J.; Lynch, J. K. J. Med. Chem. 1997, 40, 4169-4194. Elgen, R. M.; Hunter, J. C.; Dray, A. Trends Pharm. Sci. 1999, 20, 337-342.
3. For introductions to nicotine pharmacology and the interest in nicotinic agonists and antagonists, see: Bannon, A. W., et al. Science 1998, 279, 77-81. Holladay, M. W.; Dart, M. J.; Lynch, J. K. J. Med. Chem. 1997, 40, 4169-4194. Elgen, R. M.; Hunter, J. C.; Dray, A. Trends Pharm. Sci. 1999, 20, 337-342.
4. (a) Barlow, R. B.; Howard, J. A. K.; Johnson, O. Acta Crystallogr. 1986, C42, 853-856.
5. (b) Koo, C. H.; Kim, H. S. Daehan Hwahak Hwoejee 1965, 9, 134-141. Koo, C. H.; Kim, H. S. Chem. Abstr. 1966, 64, 6431e.
6. (b) Koo, C. H.; Kim, H. S. Daehan Hwahak Hwoejee 1965, 9, 134-141. Koo, C. H.; Kim, H. S. Chem. Abstr. 1966, 64, 6431e.
7. Chynoweth, K. R.; Ternai, B.; Simeral, L. S.; Maciel, G. E. Mol. Pharmacol. 1973, 9, 144-151.
8. Whidby, J. F.; Seeman, J. I. J. Org. Chem. 1976, 41, 1585-1590.
9. Pitner, T. P.; Edwards, W. B., III; Bassfield, R. L.; Whidby, J. F. J. Am. Chem. Soc. 1978, 100, 246-251.
10. Seeman, J. I. Heterocycles 1984, 22, 165-193.
11. Whidby, J. F.; Edwards, W. B., III; Pitner, T. P. J. Org. Chem. 1979, 44, 794-798.
12. Cox, R. H.; Kao, J.; Secor, H. V.; Seeman, J. I. J. Mol. Struct. 1986, 140, 93-106.
13. Pullman, B.; Courrière, P.; Coubeils, J. L. Mol. Pharmacol. 1971, 7, 397-405.
14. Hacksell, U.; Mellin, C. Prog. Brain Res. 1989, 79, 95-100.
15. Radna, R. J.; Beveridge, D. L.; Bender, A. L. J. Am. Chem. Soc. 1973, 95, 3831-3842.
16. Berthelot, M.; Decouzon, M.; Gal, J.-F.; Laurence, C.; Le Questel, J.-V.; Maria, P.-C.; Tortajada, J. J. Org. Chem. 1991, 56, 4490-4494.
17. Kier, L. B. Mol. Pharmacol. 1988, 4, 70-76.
18. (a) Segall, M. D.; Payne, M. C.; Boyes, R. N. Mol. Phys. 1998, 93, 365-370.
19. (b) Edvardsen, Ø.; Dahl, S. G. J. Neural Transm. 1991, 83, 157-170.
20. (c) Margheritis, C.; Corongiu, G. J. Comput. Chem. 1988, 9, 1-10.
21. Campillo, N.; Páez, J. A.; Alkorta, I.; Goya, P. J. Chem. Soc., Perkin Trans. 2 1998, 2, 2665-2669.
22. Thompson, P. E.; Manallack, D. T.; Blaney, F. E.; Gallagher, T. J. Comput. Aided Mol. Design 1992, 6, 287-298.
23. Jorgensen, W. L.; Maxwell, D. S.; Tirado-Rives, J. J. Am. Chem. Soc. 1996, 118, 11225-11236.
24. (a) Nagy, P. I.; Durant, G. J. J. Chem. Phys. 1996, 104, 1452-1463.
25. (b) Nagy, P. I.; Durant, G. J.; Hoss, W. P.; Smith, D. A. J. Am. Chem. Soc. 1994, 116, 4898-4909.
26. (c) Nagy, P. I.; Takács-Novák, K. J. Am. Chem. Soc. 1997, 199, 4999-5006.
27. (d) Nagy, P. I.; Durant, G. J.; Smith, D. A. J. Am. Chem. Soc. 1993, 115, 2912-2922.
28. Jorgensen, W. L. Acc. Chem. Res. 1989, 22, 184-189.
29. (a) Li, J.; Hawkins, G. D.; Cramer, C. J.: Truhlar, D. G. Chem. Phys. Lett. 1998, 288, 293-298.
30. (b) Zhu, T.; Li, J. B.; Hawkins, G. D.; Cramer, C. J.; Truhlar, D. G. J. Chem. Phys. 1998, 109, 9117-9133.
31. SPARTAN version 5.0. Wavefunction, Inc., 18401 Von Karman Ave., Suite 370, Irvine, CA 92612.
32. Gaussian 94. Gaussian 94, Revision D.3: Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Gill, P. M. W.; Johnson, B. G.; Robb, M. A.; Cheeseman, J. R.; Keith, T.; Petersson, G. A.; Montgomery, J. A.; Raghavachari, K.; Al-Laham, M. A.; Zakrzewski, V. G.; Ortiz, J. V.; Foresman, J. B.; Cioslowski, J.; Stefanov, B. B.; Nanayakkara, A.; Challacombe, M.; Peng, C. Y.; Ayala, P. Y.; Chen, W.; Wong, M. W.; Andres, J. L.; Replogle, E. S.; Gomperts, R.; Martin, R. L.; Fox, D. J.; Binkley, J. S.; Defrees, D. J.; Baker, J.; Stewart, J. P.; Head-Gordon, M.; Gonzalez, C.; Pople, J. A. Gaussian, Inc., Pittsburgh, PA, 1995.
33. Breneman, C. M.; Wiberg, K. B. J. Comput. Chem. 1990, 11, 361-373.
34. BOSS Version 3.8. Jorgensen, W. L. Department of Chemistry, Yale University, P.O. Box 208107, New Haven, CT 06520-8107.
35. Carlson, H. A.; Nguyen, T. B.; Orozco, M.; Jorgensen, W. L. J. Comput. Chem. 1993, 14, 1240-1249.
36. Colominas, C.; Luque, F. J.; Orozco, M. J. Phys. Chem. A 1999, 103, 6200-6208.
37. sol of the other nicotine protonation states (neutral and doubly protonated) was performed using the SM5.42R HF/6-31G* parametrized model on HF/6-31G** geometries. This model was applied to these systems in lieu of SPT/OPLS simulations because it produced similar qualitative trends for the singly protonated species at a fraction of the computational expense. The same cis/trans solvation trend seen for + species was seen for other protonation states, and trans species are still predicted to be most stable in aqueous solution. But interestingly, the B rotamers for both 0 and ++ species showed better solvation than the A ones. Thus, in species where the N atoms carry a similar charge, solvation appears to improve with decreased N-N distance.
38. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. J. Med. Chem. 1986, 29, 899-906.
39. Glennon, R. A.; Herndon, J. L.; Dukat, M. Med. Chem. Res. 1994, 4, 461-473.
40. Glennon, R. A.; Dukat, M. Med. Chem. Res. 1996, 6, 465-486.